Skip to content

Abnormal Circulating Hyaluronic Acid Concentration C4531276

Published: July 22, 2026Updated: August 20, 2026

Hyaluronic acid is a substance involved in skin and joint health, and liver scarring. Elevated levels may indicate liver fibrosis or connective tissue conditions. Doctors use it along with other tests to assess the condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Yellowing of skin or eyes

Jaundice causing yellow discoloration of the skin and whites of the eyes.

Seek immediate medical attention if jaundice appears suddenly or is accompanied by severe weakness, dark urine, or pale stools.

!

Abdominal swelling

Buildup of fluid in the abdomen (ascites) causing visible swelling and fullness.

Seek prompt medical care if abdominal swelling develops suddenly, is accompanied by pain, or makes it difficult to breathe.

!

Confusion or difficulty concentrating

Mental confusion, difficulty focusing, or personality changes due to hepatic encephalopathy.

Seek emergency care immediately if confusion, disorientation, or severe drowsiness occurs, as this can indicate serious liver dysfunction.

Persistent fatigue

(constitutional)

Persistent feeling of tiredness and low energy that does not improve with rest.

Frequency: 70-80% of patients

Abdominal discomfort

(gastrointestinal)

General discomfort or dull ache in the abdominal area, often in the upper right quadrant.

Frequency: 50-60% of patients

Loss of appetite

(gastrointestinal)

Reduced desire to eat, leading to decreased food intake.

Frequency: 40-50% of patients

Spider angiomas

(dermatologic)

Small, spider-like blood vessels visible on the skin, typically on the face, chest, or arms.

Frequency: 30-40% of patients

Unexplained weight loss

(constitutional)

Losing weight without trying, often due to decreased appetite and metabolism changes.

Frequency: 30-40% of patients

Skin itching

(dermatologic)

Generalized itching (pruritus) without visible skin rash, often worse at night.

Frequency: 15-20% of patients

Easy bruising

(hematologic)

Bruising or bleeding more easily than normal due to reduced liver function and clotting factor production.

Frequency: 30-40% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive biomarker tracking

Regular assessment of hyaluronic acid levels along with related inflammatory markers to establish baseline values and monitor trends over time.

monitoring
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Collagen precursor supplementation

Oral supplements containing compounds that support endogenous hyaluronic acid production and skin/joint health. Includes ingredients like vitamin C and amino acids.

complementary

Additional treatment options

Anti-inflammatory nutrition plan

Dietary approach emphasizing whole foods, omega-3 fatty acids, and antioxidants to reduce systemic inflammation that may affect hyaluronic acid metabolism.

dietary

Hydration optimization

Increased water intake to support proper distribution and function of hyaluronic acid throughout connective tissues and joints.

lifestyle

Joint mobility and strengthening program

Targeted exercises to maintain joint health and support connective tissue function. Includes range of motion work and progressive resistance training.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Hyaluronic Acid Concentration C4531276?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021;75(3):659-689.

guideline2021View source →
2

AASLD Expert Panel. AASLD Guidelines for the Treatment of Hepatocellular Carcinoma. Hepatology. 2022;75(4):1012-1054.

guideline2022View source →
3

Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest and ActiTest in chronic hepatitis C: the influence of genotype, viral load, ALT level, and newly developed algorithms. J Viral Hepat. 2011;18(8):535-543.

review2011View source →
4

Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004;127(6):1704-1713.

review2004View source →
5

Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726-736.

meta_analysis2011View source →
6

Mytilinaios DG, Marvaki S, Saridi M, et al. Hyaluronic acid serum levels in patients with liver fibrosis. J Clin Lab Anal. 2012;26(4):267-271.

clinical_trial2012View source →
7

Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293-1302.e4.

review2012View source →
8

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Hepatitis B virus infection. J Hepatol. 2017;66(2):398-430.

position_statement2017View source →
9

Bedossa P, Carrat F. Liver fibrosis: current status of invasive methods and non-invasive biomarkers. J Hepatol. 2012;56(5):1170-1180.

review2012View source →
10

Houot M, Ngo Y, Munteanu M, Poynard T. Systematic review of biomarker-based prognostic models for chronic liver disease. Hepatology. 2016;64(5):1535-1546.

meta_analysis2016View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Hyaluronic Acid Concentration C4531276. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy